AksharChem Q2FY27 Results: Net profit turns positive at ₹1,332 lakh

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Net profit for Q2FY27 stood at ₹1,332.16 lakh, reversing a loss of ₹136.90 lakh in Q2FY26
  • Revenue from operations grew 79.7% YoY to ₹1,604.82 crore
  • Trade receivables increased to ₹9,698.05 lakh from ₹6,240.70 lakh as on March 31, 2026
  • Munjal M. Jaykrishna re-appointed as MD & CEO for three years subject to shareholder approval
powered bylight_fuzz_icon
53957828

*this image is generated using AI for illustrative purposes only.

AksharChem (India) Limited reported a net profit of ₹1,332.16 lakh for the quarter ended September 30, 2026 (Q2FY27), marking a significant turnaround from the loss of ₹136.90 lakh recorded in Q2FY26.

The specialty chemicals manufacturer saw robust top-line growth, with revenue from operations rising 79.7% YoY to ₹1,604.82 crore. On a sequential basis, revenue expanded 13.9% from ₹1,408.70 crore in Q1FY27. The Board of Directors approved these unaudited financial results on October 19, 2026, alongside key management appointments.

Financial Performance Highlights

The company’s operational momentum was reflected in its profit before tax (PBT), which stood at ₹1,408.53 lakh in Q2FY27, compared to a PBT loss of ₹140.47 lakh in the corresponding period last year. The half-year figures also showed strong recovery, with H1FY27 PBT at ₹3,003.34 lakh against H1FY26 PBT loss of ₹37.24 lakh.

Metric Q2FY27 Q2FY26 Change
Revenue from Operations ₹1,604.82 crore ₹893.02 crore +79.7%
Profit Before Tax ₹140.85 crore -₹14.05 crore Turnaround
Net Profit ₹133.22 crore -₹13.69 crore Turnaround
EPS (Basic) ₹16.58 -₹1.70 N/A

Note: Revenue figures converted from lakhs to crores for readability where applicable in analysis, but source data is in lakhs.

Management Appointments and Governance

In addition to the results, the Board approved the change in designation and re-appointment of Munjal M. Jaykrishna as Managing Director & CEO for a term of three years effective October 19, 2026. This appointment is subject to shareholder approval.

Furthermore, the Board recommended the revision in remuneration for Sachin M. Jaykrishna, Whole Time Director, effective October 19, 2026. His re-appointment as Whole Time Director for a three-year term starting August 2, 2027, was also approved, subject to necessary regulatory and shareholder approvals.

What the Numbers Show

A closer look at the balance sheet reveals a divergence between profit growth and cash flow efficiency. While net profit turned significantly positive, trade receivables surged to ₹9,698.05 lakh as on September 30, 2026, up from ₹6,240.70 lakh as on March 31, 2026. This increase of over ₹3,400 lakh suggests that a substantial portion of the revenue growth has not yet been converted into cash inflows, potentially indicating extended credit periods or collection delays despite the strong sales performance.

Additionally, inventory levels rose to ₹8,571.90 lakh from ₹7,300.95 lakh in the same period, aligning with the higher production volumes required to support the 79.7% YoY revenue jump. The company’s cash position remains lean at ₹16.97 lakh, highlighting a reliance on working capital financing to manage the increased receivables and inventory cycles.

Historical Stock Returns for AksharChem

1 Day5 Days1 Month6 Months1 Year5 Years
-0.78%+11.45%+8.57%+112.85%+54.97%0.0%

How will AksharChem address the significant gap between surging trade receivables and its lean cash position to mitigate working capital risks in the next quarter?

What specific product segments or export markets drove the 79.7% YoY revenue growth, and is this momentum sustainable given global specialty chemical demand trends?

Will the re-appointment of the Jaykrishna family leadership team lead to a shift in capital allocation strategy, particularly regarding debt reduction versus capacity expansion?

AksharChem AGM resolutions pass with 99.83% votes in favour

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • All five AGM resolutions passed with 99.83% votes in favour
  • Promoter group cast 5,036,537 votes supporting all agenda items
  • Public non-institutional shareholders voted against with 8,646 votes
  • Meeting held on September 22, 2026, with e-voting concluded September 21
powered bylight_fuzz_icon
51607801

*this image is generated using AI for illustrative purposes only.

AksharChem (India) Limited adopted the audited financial statements for the year ended March 31, 2026, at its 37th Annual General Meeting held on September 22, 2026. The meeting also approved the declaration of a final dividend for the fiscal year.

The shareholders ratified five key resolutions through remote e-voting and poll. These included the adoption of the Board's Report and Auditors' Report alongside the financial statements. The re-appointment of two directors retiring by rotation was also confirmed.

Resolutions Passed

The following businesses were transacted during the meeting:

  • Adoption of Audited Financial Statements for FY26.
  • Declaration of Final Dividend for FY26.
  • Re-appointment of Mrs. Paru M. Jaykrishna as Director.
  • Re-appointment of Mr. Sachin M. Jaykrishna as Director.
  • Ratification of remuneration payable to Cost Auditors.

The proceedings were conducted in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Detailed voting results are being submitted separately to the exchanges.

Voting Results Breakdown

The company submitted the scrutinizer's report and voting results to BSE and NSE on September 23, 2026. The data reveals that all five ordinary resolutions passed with overwhelming majority support from the promoter group.

Resolution Votes in Favour Votes Against % In Favour Result
Adoption of FY26 Financial Statements 5,038,989 8,646 99.83% Passed
Declaration of Final Dividend FY26 5,038,989 8,646 99.83% Passed
Re-appointment of Mrs. Paru M. Jaykrishna 5,038,989 8,646 99.83% Passed
Re-appointment of Mr. Sachin M. Jaykrishna 5,038,989 8,646 99.83% Passed
Ratification of Cost Auditor Remuneration 5,038,989 8,646 99.83% Passed

Scrutinizer Details and Meeting Logistics

Bipin L. Makwana, Company Secretary in Practice, served as the scrutinizer for the meeting. The remote e-voting window opened on September 18, 2026, at 9:00 am and closed on September 21, 2026, at 5:00 pm. The physical poll was conducted during the AGM on September 22, 2026, between 12:00 pm and 12:30 pm.

A total of 10,938 shareholders were on the record date of September 15, 2026. Among them, 4 promoters and 36 public shareholders attended the meeting either in person or through proxy. No shareholders participated via video conferencing.

Historical Stock Returns for AksharChem

1 Day5 Days1 Month6 Months1 Year5 Years
-0.78%+11.45%+8.57%+112.85%+54.97%0.0%

How will the declared final dividend impact AksharChem's cash flow and future capital expenditure plans for FY27?

What specific growth strategies or new product lines did the Board highlight in the audited FY26 report to drive future revenue?

Given the low public shareholder participation, how might the company improve investor engagement and governance transparency in upcoming quarters?

More News on AksharChem

1 Year Returns:+54.97%